About Tengion (OTCMKTS:TNGN)
Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient's own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company's product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:TNGN
CUSIPN/A
Phone+1-336-7225855
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on Assets-618.10%
Miscellaneous
EmployeesN/A
Outstanding Shares36,620,000
Tengion (OTCMKTS:TNGN) Frequently Asked Questions
What is Tengion's stock symbol?
Tengion trades on the OTCMKTS under the ticker symbol "TNGN."
Who are Tengion's key executives?
Tengion's management team includes the folowing people:
- David I. Scheer, Independent Chairman of the Board (Age 63)
- Carl-Johan Dalsgaard M.D., Independent Director (Age 56)
- Diane K. Jorkasky M.D., Independent Director (Age 61)
- Richard E. Kuntz M.D., Independent Director (Age 58)
- Lorin Jeffry Randall, Independent Director
Has Tengion been receiving favorable news coverage?
Press coverage about TNGN stock has been trending somewhat positive recently, according to Accern. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tengion earned a news sentiment score of 0.22 on Accern's scale. They also gave media stories about the company an impact score of 45.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Tengion?
Shares of TNGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tengion's stock price today?
One share of TNGN stock can currently be purchased for approximately $0.0005.
How big of a company is Tengion?
Tengion has a market capitalization of $20,120.00.
How can I contact Tengion?
Tengion's mailing address is 3929 Westpoint Blvd Ste G, WINSTON SALEM, NC 27103-6761, United States. The company can be reached via phone at +1-336-7225855.
MarketBeat Community Rating for Tengion (TNGN)
MarketBeat's community ratings are surveys of what our community members think about Tengion and other stocks. Vote "Outperform" if you believe TNGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tengion (OTCMKTS:TNGN) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/24/2016 forward)
Tengion (OTCMKTS:TNGN) Earnings History and Estimates Chart
Tengion (OTCMKTS TNGN) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/9/2011 | | ($0.29) | ($0.28) | | | View | N/A |  |
(Earnings results data provided by Zacks Investment Research)
Tengion (OTCMKTS:TNGN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Tengion (OTCMKTS TNGN) Insider Trading and Institutional Ownership History
Tengion (OTCMKTS TNGN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Tengion (OTCMKTS TNGN) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Tengion (OTCMKTS:TNGN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tengion (OTCMKTS:TNGN) Income Statement, Balance Sheet and Cash Flow Statement
Tengion (OTCMKTS TNGN) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
